Skip to content

Clinical trials

Completed Phase 2 Autism Spectrum Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 2 Status: Completed Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20072
20081
20092
20103
20115
20126
20137
20144
20153
20165
20174
20184
20194
20204
20217
20226
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed77

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Holland Bloorview Kids Rehabilitation Hospital6
Evdokia Anagnostou4
Emory University2
Fei Li2
Forest Laboratories2
Hoffmann-La Roche2
Indiana University2
Joanne Kurtzberg, MD2
Sarah Keim2
Seaside Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder77
Autistic Disorder30
Asperger Syndrome6
Anxiety Disorders4
Developmental Disabilities3
Fragile X Syndrome2
Nervous System Diseases2
Neurodevelopmental Disorders2
Sleep Initiation and Maintenance Disorders2
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.